• Western blot analysis of lysates from SW480 cells, primary antibody was diluted at 1:1000, 4°C over night

Anti-SCYL3 antibody (519-569 aa) (STJ193823)

SKU:
STJ193823

Current Stock:
Host: Rabbit
Applications: WB
Reactivity: Human/Mouse
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-Protein-associating with the carboxyl-terminal domain of ezrin (519-569 aa) is suitable for use in Western Blot research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide.
Purification: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Concentration: 1 mg/mL
Dilution Range: WB 1:500-2000
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: SCYL3
Gene ID: 57147
Uniprot ID: PACE1_HUMAN
Immunogen Region: 519-569 aa
Specificity: This antibody detects endogenous levels of PACE1 at Human/Mouse
Immunogen: Synthesized peptide derived from the human PACE1 at the amino acid range 519-569
Post Translational Modifications May be myristoylated.myristoylation may target it to Golgi compartment. Phosphorylated.
Function May play a role in regulating cell adhesion/migration complexes in migrating cells.
Protein Name Protein-Associating With The Carboxyl-Terminal Domain Of Ezrin
Ezrin-Binding Protein Pace-1
Scy1-Like Protein 3
Cellular Localisation Cytoplasm
Golgi Apparatus
Cell Projection
Lamellipodium
Colocalized With Ezr/Vil2
Actin And Cd44 In Lamellipodia
Alternative Antibody Names Anti-Protein-Associating With The Carboxyl-Terminal Domain Of Ezrin antibody
Anti-Ezrin-Binding Protein Pace-1 antibody
Anti-Scy1-Like Protein 3 antibody
Anti-SCYL3 antibody
Anti-PACE1 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance